Rockwell Medical, Inc.
RMTI
$7.96
-$0.11-1.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 17.78M | 17.34M | 18.35M | 15.93M | 16.07M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 17.78M | 17.34M | 18.35M | 15.93M | 16.07M |
| Cost of Revenue | 14.54M | 14.44M | 14.47M | 13.66M | 13.57M |
| Gross Profit | 3.24M | 2.90M | 3.88M | 2.27M | 2.50M |
| SG&A Expenses | 4.26M | 4.38M | 4.28M | 3.86M | 3.85M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 18.84M | 18.82M | 18.74M | 17.51M | 17.42M |
| Operating Income | -1.06M | -1.48M | -398.00K | -1.58M | -1.35M |
| Income Before Tax | -1.17M | -1.61M | -554.00K | -1.75M | -1.49M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.17M | -1.61M | -554.00K | -1.75M | -1.49M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.17M | -1.61M | -554.00K | -1.75M | -1.49M |
| EBIT | -1.06M | -1.48M | -398.00K | -1.58M | -1.35M |
| EBITDA | -569.00K | -969.00K | 148.00K | -1.04M | -786.00K |
| EPS Basic | -0.34 | -0.41 | -0.14 | -0.49 | -0.48 |
| Normalized Basic EPS | -0.21 | -0.27 | -0.10 | -0.31 | -0.28 |
| EPS Diluted | -0.34 | -0.41 | -0.15 | -0.50 | -0.48 |
| Normalized Diluted EPS | -0.21 | -0.27 | -0.10 | -0.31 | -0.28 |
| Average Basic Shares Outstanding | 3.96M | 3.94M | 3.94M | 3.60M | 3.43M |
| Average Diluted Shares Outstanding | 3.96M | 3.94M | 3.94M | 3.60M | 3.43M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |